��������

Daniel Adams is the Executive Chairman and Co‐Founder of NextWaveBio, a next‐generation biotechnology enterprise developing safer, more affordable pharmaceuticals. Previously, Dan founded and managed several biotechnology companies including Biogen that achieved a combined value of well in excess of $60 billion.